Abstract:Background: Perineural invasion (PNI) is an important mechanism associated with metastasis in malignancies, including intrahepatic cholangiocarcinoma (ICC), and is correlated with poor prognosis. However, the molecular features and their relationship with the prognosis of ICC patients with PNI remain unclear.Methods: Prognostic implications of PNI were investigated in MSK cohort and was validated in our independent cohort of patients with ICC using the Kaplan–Meier method. PNI-related genomic profiles were analyzed in the MSK cohort, and the PNI-related transcriptomic atlas was examined in the ZS-ICC cohort from our team. GO, KEGG, and ssGSEA analysis were performed. Immunohistochemistry was used to investigate the relationship between PNI and markers of neurons, hydrolases, and immune cells. The efficacy of adjuvant therapy in ICC patients with PNI was also assessed.Findings: A total of 30.6% and 20.7% patients with ICC had PNI in the discovery and validation cohorts respectively. Patients with PNI in both cohorts presented with shortened overall survival (OS) and relapse-free survival (RFS). The PNI showed positive expression of tyrosine hydroxylase (TH), a marker of sympathetic nerves. Patients with PNI showed a high frequency of KRAS mutations, decreased NK cell infiltration, increased neutrophil infiltration, and elevated expression of PD-L1, CD80, and CD86. Patients with PNI benefited from an extended OS after adjuvant therapy with TEGIO, GEMOX, or capecitabine.Interpretation: Our study deciphered the molecular features of a high frequency of KRAS mutation, positive TH expression, increased neutrophil infiltration, and decreased NK cell infiltration in ICC patients with PNI. Patients with PNI showed a poor prognosis after surgery but a good response to adjuvant chemotherapy.Funding Information: This study was supported by the Clinical Research Plan of SHDC (SHDC 2020CR1003A), the Key Disease Joint Research Program of Xuhui District (XHLHGG202103), the National Key Research and Development Program of China (2019YFC1316000), the National Natural Science Foundation of China (81972232), the Clinical Medicine Research Pilot Project of Shanghai Medical School of Fudan University, the Shanghai Municipal Natural Science Foundation (20JC1419103), Beijing Mutual Care Public Welfare Foundation (GDXZ-08-05) and Sanming Project of Medicine in Shenzhen (No. SZSM202003009).Declaration of Interests: There is no competing interest between all authors.Ethics Approval Statement: The study was approved by the Institutional Review Board of Zhongshan Hospital (Y2017-130), and all related procedures conformed to the Declaration of Helsinki.

Somatic Mutation Profiling of Intrahepatic Cholangiocarcinoma: Comparison between Primary and Metastasis Tumor Tissues

Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets

Integrated Bioinformatics Analysis and Clinical Validation Reveals That High Expression of Mucin 1 in Intrahepatic Cholangiocarcinoma Predicts Recurrence after Curative Resection.

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma

Comprehensive Molecular Profiling of Intrahepatic Cholangiocarcinoma in the Chinese Population and Therapeutic Experience

Mutational landscape of intrahepatic cholangiocarcinoma

Prognostic Values Of Prevalent Gene Mutations In Intrahepatic Cholangiocarcinoma

Genetic Alterations of KRAS and TP53 in Intrahepatic Cholangiocarcinoma Associated with Poor Prognosis.

Exploring the Clinical Use of Molecular Profiling of Intrahepatic Cholangiocarcinoma in a Comprehensive Multidisciplinary Clinic

Distinct Clinical and Prognostic Implication of IDH1/2 Mutation and Other Most Frequent Mutations in Large Duct and Small Duct Subtypes of Intrahepatic Cholangiocarcinoma

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma

Genetic Profiling of Intrahepatic Cholangiocarcinoma and Its Clinical Implication in Targeted Therapy.

Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.

Multi-omics-driven Discovery of Invasive Patterns and Treatment Strategies in CA19-9 Positive Intrahepatic Cholangiocarcinoma

The Clinical Implications and Molecular Features of Intrahepatic Cholangiocarcinoma with Perineural Invasion.

Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study

The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations

Molecular Profiling and Prognostic Analysis in Chinese Cholangiocarcinoma: an Observational, Retrospective Single-Center Study.

Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma

Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing–Assisted Multiomics Analysis